Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.52 |
| ▸ | GNPAT | O15228 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 4/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.48 |
| ▸ | NPY1R | P25929 | 3/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 1/20 | 0.46 |
| ▸ | FNTB | P49356 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17304349 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304352 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304342 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304354 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304347 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304345 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304348 | 1.00 | NOD1 (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304356 | 0.99 | GNPAT (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL17304344 | 0.99 | GNPAT (0.52) | NOD1GNPATNPY4RNPY5RNPY1R | |
| SCHEMBL3651453 | 0.97 | NOD1 (0.55) | NOD1GNPATNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240050502-A1 | AMANITA MUSCARIA COMPOUNDS | CAAMTECH, INC. | 2024-02-15 | — | — | US | disclosed |
| US-20230355701-A1 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | CAAMTECH, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| EP-4262775-A1 | AMANITA MUSCARIA COMPOUNDS | Caamtech, Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20220273620-A1 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | CAAMTECH, INC. | 2022-09-01 | — | — | US | disclosed |
| WO-2022132691-A1 | AMANITA MUSCARIA COMPOUNDS | CAAMTECH, INC. (US) | 2022-06-23 | — | — | WO | disclosed |
| EP-4003395-A1 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | Caamtech, Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| US-11013704-B2 | Compounds supports hematopoietic stem cells and red blood cells | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-05-25 | — | — | US | disclosed |
| US-20170304240-A1 | NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2017-10-26 | — | — | US | disclosed |
| WO-2015183545-A1 | NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2015-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170304240-A1 | NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS | EPOR, THPO, MCL1 | NOD1 4864/4885GNPAT 2435/4885NPY4R 4400/4885 |
| US-20230355701-A1 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | HTR3A, HTR7, HTR5A | NOD1 2108/4885GNPAT 2936/4885NPY4R 671/4885 |
| US-20220273620-A1 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | HTR5A, DIMT1, GART | NOD1 1876/4885GNPAT 351/4885NPY4R 960/4885 |
| US-11013704-B2 | Compounds supports hematopoietic stem cells and red blood cells | EPOR, THPO, MCL1 | NOD1 4866/4885GNPAT 2056/4885NPY4R 4600/4885 |
| US-20240050502-A1 | AMANITA MUSCARIA COMPOUNDS | HTR3A, MANBA, MGAT2 | NOD1 1204/4885GNPAT 188/4885NPY4R 2301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.